Digital Checkup (602)

Oren Nissim, CEO of Brook Health, discusses the program, which starts on July 5, and what broadening providers' access to certain tech-enabled care options could mean for Medicare beneficiaries with chronic conditions.

The biggest risks of healthcare artificial intelligence are not necessarily the known deficiencies of AI technology. "The real risk is automation complacency," says Ben Scharfe, EVP of AI at Altera Digital Health.

Brain Imaging Adaptive Core, or BrainIAC, holds huge promise for an array of important neurology research use cases, says Dr. Benjamin Kann, of the Artificial Intelligence in Medicine Program at Mass General Brigham.

Vikram Bhaskaran and Dr. Rohan Ramakrishna, Roon cofounders, discuss the importance of enabling connectivity between physicians globally following the WHO's declaration of Ebola as a Public Health Emergency of International Concern.

Omega Healthcare works with hospitals on rev cycle tools, making tweaks in such areas as data and population that make each provider unique, says CEO Anurag Mehta.

Fragmented identifiers in healthcare and a federated governance model can inhibit trusted access, explains Patrick Lane, president and COO of Health Gorilla.

Michael Martin, founder and CEO of RapidSOS, discusses the company's partnership with Oscar-nominated actor Jeremy Renner and how real-time data from wearables, vehicles and connected systems can shape the future of emergency response.

According to Michael Meucci, Arcadia's president and CEO, marrying data about patients, care journeys, costs and more for AI to analyze can uncover utilization signals that providers and payers can use to enhance care delivery.

"You really have to be thoughtful about safeguarding the data," says Andy Crowder, SVP and chief data and AI officer of Advocate Health. The provider has been using Agent Factory, Epic's EHR-integrated artificial intelligence development tool.

Continued funding from the federal Rural Health Transformation Program requires integrated data across providers. Making it easy for them to connect virtually to state systems is vital, says Dr. Tim Ferris, InterSystems' VP of healthcare practice.

The legislation will give greater insight into the cost of therapies, but it doesn't mean premiums or the price of drugs will go down, says Ryan Czado, chief pharmacy officer of RazorMetrics.

Dr. Alex Pastuszak, cofounder and CEO of Paterna Biosciences, discusses the company’s recent announcement that it grew human sperm in a lab and used it to create embryos with the goal of impacting the future of male fertility treatment.